Low dose morphine lowers objective cough frequency in IPF

Receiving a 5 mg dose of controlled-release morphine twice daily for 14 days lowered objective cough frequency in patients with idiopathic pulmonary fibrosis, according to results published in The Lancet Respiratory Medicine.
“This multicenter study shows that low-dose controlled-release morphine is effective in reducing awake cough frequency and improving quality of life in participants with significant IPF-related cough,” Zhe Wu, MD, of the National Heart and Lung Institute at Imperial College London, and colleagues wrote.
In a prospective, multicenter, randomized, double-blind,

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart